Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
Development and Psychopathology
|
July 1, 1997
Follow-up study of young stress-affected and stress-resilient urban children
E L Cowen, P A Wyman, W C Work, et al.
Journal of Medicinal Chemistry
|
June 26, 1992
Substituent variation in azabicyclic triazole- and tetrazole-based muscarinic receptor ligands
S M Jenkins, H J Wadsworth, S Bromidge, et al.
Journal of the American Academy of Child and Adolescent Psychiatry
|
September 1, 1992
Interviews with children who experienced major life stress: family and child attributes that predict resilient outcomes
P A Wyman, E L Cowen, W C Work, et al.
Journal of Medicinal Chemistry
|
June 1, 1986
7-Aroyl-2,3-dihydrobenzo[b]furan-3-carboxylic acids and 7-benzoyl-2,3-dihydrobenzo[b]thiophene-3-carboxylic acids as analgesic agents
E A Boyle, F R Mangan, R E Markwell, et al.
Bioorganic & Medicinal Chemistry
|
February 1, 1996
Azabicyclic indole esters as potent 5-HT4 receptor antagonists
P A Wyman, L M Gaster, F D King, et al.
Neuropharmacology
|
December 5, 2003
Identification and characterisation of SB-366791, a potent and selective vanilloid receptor (VR1/TRPV1) antagonist
M J Gunthorpe, H K Rami, J C Jerman, et al.
Journal of Medicinal Chemistry
|
May 9, 1998
The selective 5-HT1B receptor inverse agonist 1'-methyl-5-[[2'-methyl-4'-(5-methyl-1,2, 4-oxadiazol-3-yl)biphenyl-4-yl]carbonyl]-2,3,6,7-tetrahydro- spiro[furo[2,3-f]indole-3,4'-piperidine] (SB-224289) potently blocks terminal 5-HT autoreceptor function both in vitro and in vivo
L M Gaster, F E Blaney, S Davies, et al.
Journal of Medicinal Chemistry
|
May 30, 1998
Novel and selective 5-HT2C/2B receptor antagonists as potential anxiolytic agents: synthesis, quantitative structure-activity relationships, and molecular modeling of substituted 1-(3-pyridylcarbamoyl)indolines
S M Bromidge, S Dabbs, D T Davies, et al.
Journal of Medicinal Chemistry
|
March 29, 2000
Biarylcarbamoylindolines are novel and selective 5-HT(2C) receptor inverse agonists: identification of 5-methyl-1-[[2-[(2-methyl-3-pyridyl)oxy]- 5-pyridyl]carbamoyl]-6-trifluoromethylindoline (SB-243213) as a potential antidepressant/anxiolytic agent
S M Bromidge, S Dabbs, D T Davies, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
Development and Psychopathology
|
July 1, 1997
Follow-up study of young stress-affected and stress-resilient urban children
E L Cowen, P A Wyman, W C Work, et al.
Journal of Medicinal Chemistry
|
June 26, 1992
Substituent variation in azabicyclic triazole- and tetrazole-based muscarinic receptor ligands
S M Jenkins, H J Wadsworth, S Bromidge, et al.
Journal of the American Academy of Child and Adolescent Psychiatry
|
September 1, 1992
Interviews with children who experienced major life stress: family and child attributes that predict resilient outcomes
P A Wyman, E L Cowen, W C Work, et al.
Journal of Medicinal Chemistry
|
June 1, 1986
7-Aroyl-2,3-dihydrobenzo[b]furan-3-carboxylic acids and 7-benzoyl-2,3-dihydrobenzo[b]thiophene-3-carboxylic acids as analgesic agents
E A Boyle, F R Mangan, R E Markwell, et al.
Bioorganic & Medicinal Chemistry
|
February 1, 1996
Azabicyclic indole esters as potent 5-HT4 receptor antagonists
P A Wyman, L M Gaster, F D King, et al.
Neuropharmacology
|
December 5, 2003
Identification and characterisation of SB-366791, a potent and selective vanilloid receptor (VR1/TRPV1) antagonist
M J Gunthorpe, H K Rami, J C Jerman, et al.
Journal of Medicinal Chemistry
|
May 9, 1998
The selective 5-HT1B receptor inverse agonist 1'-methyl-5-[[2'-methyl-4'-(5-methyl-1,2, 4-oxadiazol-3-yl)biphenyl-4-yl]carbonyl]-2,3,6,7-tetrahydro- spiro[furo[2,3-f]indole-3,4'-piperidine] (SB-224289) potently blocks terminal 5-HT autoreceptor function both in vitro and in vivo
L M Gaster, F E Blaney, S Davies, et al.
Journal of Medicinal Chemistry
|
May 30, 1998
Novel and selective 5-HT2C/2B receptor antagonists as potential anxiolytic agents: synthesis, quantitative structure-activity relationships, and molecular modeling of substituted 1-(3-pyridylcarbamoyl)indolines
S M Bromidge, S Dabbs, D T Davies, et al.
Journal of Medicinal Chemistry
|
March 29, 2000
Biarylcarbamoylindolines are novel and selective 5-HT(2C) receptor inverse agonists: identification of 5-methyl-1-[[2-[(2-methyl-3-pyridyl)oxy]- 5-pyridyl]carbamoyl]-6-trifluoromethylindoline (SB-243213) as a potential antidepressant/anxiolytic agent
S M Bromidge, S Dabbs, D T Davies, et al.
Page
of 2